Andrew Bond rates CME a sell due to growing competition. The...

Andrew Bond rates CME a sell due to growing competition. The analyst speculates that CME could acquire CBOE following their CEO's departure, despite potential difficulties. Bond suggests investors seek more stable revenue sources for CME during non-turbulent market periods.